Phoslo and Glucotrol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Phoslo (calcium acetate) and Glucotrol (glipizide). Common drug interactions include pruritus among females and nephrogenic systemic fibrosis among males.

The phase IV clinical study analyzes what interactions people have when they take Phoslo and Glucotrol. It is created by eHealthMe based on reports of 52 people who take the same drugs from the FDA, and is updated regularly.

What is Phoslo?

Phoslo has active ingredients of calcium acetate. eHealthMe is studying from 4,291 Phoslo users. Check the latest studies of Phoslo.

What is Glucotrol?

Glucotrol has active ingredients of glipizide. It is often used in diabetes. eHealthMe is studying from 20,322 Glucotrol users. Check the latest studies of Glucotrol.



On Aug, 11, 2026

52 people who take Phoslo and Glucotrol together, and have interactions are studied.

Phoslo and Glucotrol drug interactions.

What are the common drug interactions of Phoslo and Glucotrol, by gender? *:

female:

  1. Pruritus (severe itching of the skin)
  2. Renal disorder (kidney disease)
  3. Renal failure acute (rapid kidney dysfunction)
  4. Renal injury (kidney injury)
  5. Stress
  6. Vomiting
  7. Abdominal pain upper
  8. Activities of daily living impaired
  9. Apnoea (suspension of external breathing)
  10. Blood creatinine increased

male:

  1. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  2. Joint contracture (a permanent shortening of a muscle or joint)
  3. Skin fibrosis (fibrous tissue formation on skin)
  4. Skin tightness
  5. Chronic kidney disease
  6. Nephrogenic anaemia (anaemia due to kidney disease)
  7. Renal failure (kidney dysfunction)
  8. Aspartate aminotransferase increased
  9. Bile duct obstruction (blockage in the tubes that carry bile from the liver to the gallbladder)
  10. Blood alkaline phosphatase nos increased

What are the common drug interactions of Phoslo and Glucotrol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Chronic kidney disease
  2. Nephrogenic anaemia (anaemia due to kidney disease)

40-49:

  1. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  2. Joint contracture (a permanent shortening of a muscle or joint)
  3. Joint range of motion decreased (disease of joint movement)
  4. Oedema peripheral (superficial swelling)
  5. Skin hypertrophy (skin cells enlarges)
  6. Skin induration (an abnormally hard spot or area on the skin)
  7. Pain of skin
  8. Skin atrophy (wasting of skin)
  9. Skin hyperpigmentation (disorders affect the colour of your skin)
  10. Skin ulcer

50-59:

  1. Activities of daily living impaired
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Anxiety
  4. Dermatitis exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss)
  5. Emotional distress
  6. Hyperkeratosis (thickening of the outer layer of the skin)
  7. Joint range of motion decreased (disease of joint movement)
  8. Mobility decreased (ability to move is reduced)
  9. Parakeratosis
  10. Pitting oedema (skin discoloration)

60+:

  1. Asthenia (weakness)
  2. Death
  3. Constipation
  4. Dyspnoea (difficult or laboured respiration)
  5. Emotional distress
  6. Fear
  7. Fluid overload (too much fluid in the blood)
  8. Heart injury
  9. Hepatic failure (liver failure)
  10. Hepatocellular damage (liver damage)

What are the existing conditions these people have? *

  1. High Blood Pressure: 7 people, 13.46%
  2. High Blood Cholesterol: 7 people, 13.46%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 13.46%
  4. Type 2 Diabetes: 6 people, 11.54%
  5. Pain: 6 people, 11.54%
  6. Multiple Allergies (allergy to multiple agents): 5 people, 9.62%
  7. Fluid Retention (an abnormal accumulation of fluid in the blood): 5 people, 9.62%
  8. Hot Flush (sudden feelings of heat): 4 people, 7.69%
  9. Dyspnea (difficult or laboured breathing): 3 people, 5.77%

* Approximation only. Some reports may have incomplete information.

Do you take Phoslo and Glucotrol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Phoslo and Glucotrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Phoslo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Glucotrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Phoslo and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Glucotrol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on calcium acetate and glipizide (the active ingredients of Phoslo and Glucotrol, respectively), and Phoslo and Glucotrol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: